{"version":"1.0","provider_name":"Oxford","provider_url":"https:\/\/www.oxfordcorp.com\/fr\/","author_name":"jfranzen","author_url":"https:\/\/www.oxfordcorp.com\/fr\/insights\/author\/jfranzen\/","title":"IVDR Compliance: The Main Challenges Ahead","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"AnWsAF288V\"><a href=\"https:\/\/www.oxfordcorp.com\/fr\/insights\/blog\/ivdr-compliance-main-challenges-ahead\/\">IVDR Compliance: The Main Challenges Ahead<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.oxfordcorp.com\/fr\/insights\/blog\/ivdr-compliance-main-challenges-ahead\/embed\/#?secret=AnWsAF288V\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0IVDR Compliance: The Main Challenges Ahead\u00a0\u00bb &#8212; Oxford\" data-secret=\"AnWsAF288V\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.oxfordcorp.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2020\/04\/ivdr-header.jpg","thumbnail_width":1920,"thumbnail_height":680,"description":"In May 2017, EU officials announced regulations impacting organizations that manufacture in vitro diagnostic devices in both Europe and the US. In order to sell their products on the European market, organizations must achieve compliance by May 2022."}